Anticoagulants.

Br Med Bull

Department of Neurology, Central Sheffield University Hospitals NHS Trust, UK.

Published: December 2000

AI Article Synopsis

  • Anticoagulation treatment poses significant risks, especially for elderly patients and those with certain health issues like hypertension and gastrointestinal disease, necessitating careful individual assessment of risks and benefits.
  • Anticoagulants are recommended for older patients with symptomatic non-rheumatic atrial fibrillation and additional health concerns, but should not be routinely used in acute stroke cases or for secondary prevention in patients with normal heart rhythm.
  • While there might be potential for anticoagulants in specific situations like cortical venous thrombosis or carotid dissection, current evidence does not strongly support their use in these cases.

Article Abstract

Anticoagulation is a treatment with significant and life threatening complications requiring that the balance of risk and benefit be individually assessed in each patient. The risks are greater in the elderly and those with hypertension, falls and gastrointestinal disease. The use of anticoagulants is now established in patients with symptomatic non-rheumatic atrial fibrillation, especially older patients with hypertension, cardiac failure or a large left atrium or left ventricular dysfunction. There is, however, no place for the routine use of anticoagulants in acute stroke or as part of secondary prevention in patients in sinus rhythm. There may be a place, though as yet the evidence would not support this, for the limited use of anticoagulants in special situations such as cortical venous thrombosis or carotid dissection.

Download full-text PDF

Source
http://dx.doi.org/10.1258/0007142001903157DOI Listing

Publication Analysis

Top Keywords

anticoagulants
4
anticoagulants anticoagulation
4
anticoagulation treatment
4
treatment life
4
life threatening
4
threatening complications
4
complications requiring
4
requiring balance
4
balance risk
4
risk benefit
4

Similar Publications

Background: Regionally anticoagulated continuous renal replacement therapy with citrate is the first choice for critically ill patients with acute kidney injury. If citrate that reaches the patient exceeds the metabolic capacity, metabolic alkalosis will follow. Bicarbonate from the treatment fluids will also reach the patient and add to the bicarbonate load.

View Article and Find Full Text PDF
Article Synopsis
  • This study investigates the biological changes in rabbit corneas caused by two light-activated corneal stiffening methods: riboflavin with UVA and WST11 with NIR.
  • Differentially expressed proteins were identified following treatments, showing RF-D/UVA affected cell metabolism and keratocyte differentiation, while WST-D/NIR influenced extracellular matrix regulation.
  • The findings reveal a metabolic shift towards glycolysis in RF-D/UVA treated corneas compared to normal respiration in WST-D/NIR treated corneas, highlighting the distinct biological effects of each treatment.
View Article and Find Full Text PDF

Introduction: Atrial fibrillation (AF), a common heart rhythm abnormality, is linked to a higher risk of stroke. Traditionally, warfarin has been the primary anticoagulation treatment for reducing the stroke risk. The new standard of treatment by direct oral anticoagulants (DOACs) offers greater benefits including improved efficacy and fewer adverse effects with reduced monitoring.

View Article and Find Full Text PDF

Objective: Hemostatic abnormalities, including disseminated intravascular coagulation (DIC), are often cited as a common finding in patients following Loxosceles spider envenomation (ie, loxoscelism). The prevalence and severity of coagulopathy, however, particularly following L reclusa (ie, brown recluse) envenomation, is not well described. This study aimed to characterize coagulation laboratory parameters and coagulopathy in patients following L reclusa envenomation.

View Article and Find Full Text PDF

Standardization of Subcutaneous Injection of Prefilled Anticoagulants Through Lean Six Sigma Management: A Before-After Study.

J Craniofac Surg

January 2025

Department of Neurosurgery, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences.

Aim: The aim of this study was to investigate the impact of the Lean Six Sigma management approach on the standardization of nurses' prefilled anticoagulant subcutaneous injection practices, with a focus on improving anticoagulation outcomes, reducing patient complications, and enhancing overall patient satisfaction.

Background: The lack of standards for prefilled anticoagulant injection has resulted in a high complication rate, decreased patient satisfaction, and diminished service quality. This study investigated the impact of the Lean Six Sigma management approach on the standardization of nurses' prefilled anticoagulant subcutaneous injection practices.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!